The Kremlin hopes that the Russian coronavirus vaccine will soon receive its approval European Medicines Agency (Coreper), considering, in fact, that the approval should have been given a long time ago, said on Thursday the representative of the Russian president Dmitry Peshkov, acknowledging that there are some technological differences with the EMA regarding certification Sputnik-V.
“Indeed, there are some technological differences regarding the completeness of the documents and data submitted to certify our vaccine by the respective European Medicines Agency,” said Peshkov, noting that “the European some data is missing».
At the same time, he stated that the Ministry of Health and other competent authorities, such as the Russian Direct Investment Fund (RDIF), are dealing with this issue and that purely technical nature, formal procedures“, As broadcast by APE BPE.
Russia completes the bureaucratic procedures required to complete the certification of the Sputnik-V vaccine by the European Medicines Agency (EMA), the RIA news agency reported, citing the Russian Ministry of Health, adding that it expects an EMA mission to the country this year. .
The European Medicines Agency (Coreper) is unlikely to decide whether to approve Sputnik V until at least its first quarter 2022, because some data required for the review are still missing, a source familiar with the matter told Reuters.
It is reminded that and on the part of the WHO The process of approving the Russian vaccine has been “frozen”.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
